HDAC5 and pancreatic ductal adenocarcinoma: A study reported that, in pancreatic ductal adenocarcinoma, histone deacetylase 5 (HDAC5) suppresses the transcriptional activity of NF-κB by directly interacting with p65 and mediating deacetylation at K310, thereby regulating PD-L1 expression (13).